SAVE THE DATE: AHCDC 2025 AGM and Scientific Symposium
The AHCDC 2025 AGM and Scientific Symposium will be held on May 3-4, 2025, in Winnipeg, Manitoba.
A friendly reminder that this is a Rendez-Vous year for CPTHN, CHS, and the AHCDC. It will take the following schedule:
May 1: CPTHN
May 2: CHS
May 3: AHCDC
May 4: AHCDC
The Canadian Hemophilia Society (CHS) is proud to put out its call for applications for its research programs for the 2025-2026 grant period. The deadline to submit applications for all the programs is November 29, 2024. The eligibility criteria and conditions for all our research programs have been revised and updated
It is with much sadness that we report that, after a long and courageous struggle with an illness, our friend, colleague, and mentor Dr. Victor Stanley Blanchette passed away late on April 26, 2024.
AHCDC is running a 2024 competition to award up to CAD $50K for collaborative research and educational proposals that include at least 3 member centres. The finalists will be invited to present their ideas at a live presentation on May 4th, 2024, during the AHCDC 2024 AGM and Scientific Symposium in Ottawa, Ontario.
The AHCDC 2024 AGM and Scientific Symposium will take place May 3-4, 2024, in Ottawa, Ontario. Once again, we are including abstract presentations, both oral and posters.
AHCDO Haemophilia Gene therapy roadmap proposal - November 10, 2023 - Dr. Huyen Tran - Director of the Ronald Sawers HTC and the Clinical Thrombosis Service,
Melbourne, Australia
Cancellation Notice - 2020 AHCDC Annual General Meeting
Due to the rapidly evolving spread and on-going uncertainty of COVID-19 risk, the AHCDC regrets to inform you that 2020 AHCDC Annual General Meeting, which was scheduled for May 28 - 30. 2020, has been cancelled.
THSNA 2020 Summit will be in Chicago, April 23-25, 2020. Abstract submission deadline is December 13, 2019 and early bird registration deadline is December 15, 2019.
Dear AHCDC Colleagues,
With great sadness, we wish to let you know that Elianna Saidenberg passed on away Sunday October 20th after a long and courageous battle with cancer. For many of us, it is hard to imagine the loss of her vibrant spirit and energy. Elianna was passionate about her work and life. She cared deeply about her patients and her colleagues. As a physician, she would always go the extra mile to ensure her patients received the best care. She was a tireless patient advocate, particularly championing patients with insufficient financial funds. Despite her ongoing illness, she was always there to support her colleagues and friends. As a teacher and mentor, she seemed to find endless energy and enthusiasm to share her love of hematology, hemostasis, and transfusion medicine with those entering the medical profession.
Beyond everything, Elianna was devoted to her family. Our thoughts and prayers are with her husband Doron, and her daughters Abby and Joey during this difficult time. She was far too young to leave us and we will miss her deeply.
Canadian bleeding disorder medical and scientific symposium SESSION 3 - WOMEN AND BLEEDING DISORDERS Excessive bleeding in women: spotlight on hemophilia carriers Presented by Dr. Michelle Sholzberg
Canadian bleeding disorder medical and scientific symposium
SESSION 3 - WOMEN AND BLEEDING DISORDERS
Excessive bleeding in women: spotlight on hemophilia carriers
Presented by Dr. Michelle Sholzberg
A BRAVE NEW WORLD IN COAGULATION THERAPIES Can we extend far enough? Extended half-life FVIII and IX coagulation factors in Canada Presentation by Dr. Shannon Jackson
A BRAVE NEW WORLD IN COAGULATION THERAPIES
Can we extend far enough? Extended half-life FVIII and IX coagulation factors in Canada
Presentation by Dr. Shannon Jackson
Rendez-vous 2017 - Canadian bleeding disorder medical and scientific symposium SESSION 3 - WOMEN AND BLEEDING DISORDERS What can we learn by studying desmopressin responses in hemophilia carriers? Presented by Dr. Paula James
Rendez-vous 2017 - Canadian bleeding disorder medical and scientific symposium
SESSION 3 - WOMEN AND BLEEDING DISORDERS
What can we learn by studying desmopressin responses in hemophilia carriers?
Presented by Dr. Paula James
Rendez-vous 2017 - Canadian bleeding disorder medical and scientific symposium SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES Do we really need FVIII and FIX? Alternative strategies to treat hemophilia Presentation by Dr. David Lillicrap
Rendez-vous 2017 - Canadian bleeding disorder medical and scientific symposium
SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES
Do we really need FVIII and FIX? Alternative strategies to treat hemophilia
Presentation by Dr. David Lillicrap
Rendez-vous 2017 - Canadian bleeding disorder medical and scientific symposium SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES Gene therapy in hemophilia: current status and future prospects Presentation by Dr. Jerome Teitel
CHS Rendez-vous 2017 / SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIESRendez-vous 2017 - Canadian bleeding disorder medical and scientific symposium
SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES
Gene therapy in hemophilia: current status and future prospects
Presentation by Dr. Jerome Teitel